The Japanese Pharmaceutical Industry: Its Evolution and Current Challenges

ISBN-13: 9781138481435 / Angielski / Miękka / 2018 / 190 str.

Maki Umemura

Opis

Charting the development of the industry from post-war devastation, through good recovery in the 1960s, and then up to the present, the book explores why Japan, despite being a world leader in many high technology industries, is only a minor player in the global pharmaceutical industry.

Recenzje

'The Japanese Pharmaceutical Industry is an ambitious, broad-ranging analysis of the postwar history of an industry whose eight per cent share of Japanese manufacturing understates its significance in terms of health and as a barometer for science-based innovation.' - Robert Kneller, University of Tokyo; Journal of Japanese Studies, 2013.

Spis treści

1. Introduction: Why didn’t Japan become a global leader in pharmaceuticals?  2. A historical overview of Japan’s pharmaceutical industry  3. Developing a modern industry: The antibiotics sector  4. What went wrong? The anticancer drug sector  5. Conclusion: Reconsidering Japan’s business in pharmaceuticals 

O autorze

Maki Umemura is a lecturer in Japanese studies at Cardiff Business School, Cardiff University, UK.